Multidimensional development of gut-on-a-chip technology: from fabrication processes, models, gut microbiome to gut-organ axis
Journal of Pharmaceutical and Biomedical Analysis · 2026-04 · 271 · 117322
DOI: 10.1016/j.jpba.2025.117322 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026-04. Verfasst von Danni Chai und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 164 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Tianjin Municipal Science and Technology Bureau, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Gut-on-a-chip (GoC) platforms integrate microfluidics and 3D culture to replicate the intestinal microenvironment, offering physiologically relevant alternatives to traditional models. Coupled with multi-organ chips (e.g., gut-brain/gut-liver axes), they unveil microbiome-regulated systemic crosstalk via metabolite signaling-a key yet unresolved mechanism. This review highlights multidimensional advances in organ-on-chip (OoC) technologies for intestinal research, covering fabrication methods (e.g., soft lithography, bioprinting) and their applications in physiological, patient-derived, or indirectly acquired GoC models. We also emphasize breakthroughs in biomimetic intestinal-microbiome symbiosis and spatiotemporal multi-organ integration (e.g., gut-X axis), enabling emulation of complex inter-organ signaling. Yet, critical challenges persist: reproducibility is limited by fabrication variability and cell heterogeneity; standardization lacks universal benchmarks for physiological relevance; and long-term culture stability (e.g. 7-10 days) is constrained by epithelial senescence and microbial imbalance. These gaps highlight needs for standardized protocols, quality control metrics, and strategies to sustain functional homeostasis. By bridging gaps between traditional models and human biology, GoC technologies establish transformative tools for mechanistic studies and therapeutic discovery in gastroenterology and beyond.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; State Key Laboratory of Component-based Chinese Medicine, Tianjin Univers…
Förderung
- National Key Research and Development Program of China
- Tianjin Municipal Science and Technology Bureau
- Ministry of Science and Technology of the People's Republic of China
- Tianjin Municipal Science and Technology Program
Zitieren
APA
Chai, D., Wang, Q., Yong, Q., Chen, C., Liao, Y., Pan, R., He, Y., Sun, K., Liu, B., Liu, R., & Li, Z. (2026). Multidimensional development of gut-on-a-chip technology: from fabrication processes, models, gut microbiome to gut-organ axis. Journal of Pharmaceutical and Biomedical Analysis, 271, 117322. https://doi.org/10.1016/j.jpba.2025.117322
Vancouver
Chai D, Wang Q, Yong Q, Chen C, Liao Y, Pan R, et al. Multidimensional development of gut-on-a-chip technology: from fabrication processes, models, gut microbiome to gut-organ axis. Journal of Pharmaceutical and Biomedical Analysis. 2026;271:117322. doi:10.1016/j.jpba.2025.117322
BibTeX
@article{Chai2026,
author = {Chai, Danni and Wang, Quan and Yong, Qian and Chen, Chunyan and Liao, Yumeng and Pan, Ruru and He, Yujia and Sun, Keshu and Liu, Boshi and Liu, Rui and Li, Zheng},
title = {Multidimensional development of gut-on-a-chip technology: from fabrication processes, models, gut microbiome to gut-organ axis},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2026},
volume = {271},
pages = {117322},
doi = {10.1016/j.jpba.2025.117322}
}
EUVIMED